SecBot SecBot
SECBOTREPLAY Home › Report › BIO

BIO · Insider sales $899K post-Q3

BIO-RAD LABORATORIES, INC. · CLUSTER filed Nov 12, 2026 at 10:58 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Nov 12, 2026 at 10:58 ET

Two senior executives at Bio-Rad (President & COO and EVP/President of Life Science Group) sold a combined $899K in open-market shares on November 9, 2026, eight days after the company reported a Q3 earnings beat with revenue slightly above consensus but maintained guidance for a potential full-year revenue decline. The sales are not under 10b5-1 plans and follow the earnings release, suggesting possible profit-taking or portfolio rebalancing after the positive results.

  • President & COO Jonathan DiVincenzo sold 919 shares at $390.47 for $359K on Nov 9, 2026
  • EVP/President LSG James Barry sold 1,400 shares at $385.63 for $540K on Nov 9, 2026
  • Total open-market sales of $899K represent ~0.009% of Bio-Rad's $10.4B market cap
  • Neither sale was executed under a 10b5-1 plan

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access